180 related articles for article (PubMed ID: 15662832)
1. Biochemical aspects of neurodegeneration in human brain: involvement of neural membrane phospholipids and phospholipases A2.
Farooqui AA; Ong WY; Horrocks LA
Neurochem Res; 2004 Nov; 29(11):1961-77. PubMed ID: 15662832
[TBL] [Abstract][Full Text] [Related]
2. Involvement of phospholipase A2 in neurodegeneration.
Farooqui AA; Yang HC; Horrocks L
Neurochem Int; 1997 Jun; 30(6):517-22. PubMed ID: 9152992
[TBL] [Abstract][Full Text] [Related]
3. Excitatory amino acid receptors, neural membrane phospholipid metabolism and neurological disorders.
Farooqui AA; Horrocks LA
Brain Res Brain Res Rev; 1991; 16(2):171-91. PubMed ID: 1662102
[TBL] [Abstract][Full Text] [Related]
4. Glycerophospholipids in brain: their metabolism, incorporation into membranes, functions, and involvement in neurological disorders.
Farooqui AA; Horrocks LA; Farooqui T
Chem Phys Lipids; 2000 Jun; 106(1):1-29. PubMed ID: 10878232
[TBL] [Abstract][Full Text] [Related]
5. Membrane phospholipid alterations in Alzheimer's disease: deficiency of ethanolamine plasmalogens.
Farooqui AA; Rapoport SI; Horrocks LA
Neurochem Res; 1997 Apr; 22(4):523-7. PubMed ID: 9130265
[TBL] [Abstract][Full Text] [Related]
6. Excitotoxicity and neurological disorders: involvement of membrane phospholipids.
Farooqui AA; Horrocks LA
Int Rev Neurobiol; 1994; 36():267-323. PubMed ID: 7822118
[TBL] [Abstract][Full Text] [Related]
7. Phospholipase A2-generated lipid mediators in the brain: the good, the bad, and the ugly.
Farooqui AA; Horrocks LA
Neuroscientist; 2006 Jun; 12(3):245-60. PubMed ID: 16684969
[TBL] [Abstract][Full Text] [Related]
8. Phospholipase A2 and its role in brain tissue.
Farooqui AA; Yang HC; Rosenberger TA; Horrocks LA
J Neurochem; 1997 Sep; 69(3):889-901. PubMed ID: 9282910
[TBL] [Abstract][Full Text] [Related]
9. Involvement of cytosolic phospholipase A(2), calcium independent phospholipase A(2) and plasmalogen selective phospholipase A(2) in neurodegenerative and neuropsychiatric conditions.
Ong WY; Farooqui T; Farooqui AA
Curr Med Chem; 2010; 17(25):2746-63. PubMed ID: 20586719
[TBL] [Abstract][Full Text] [Related]
10. Lipid peroxides in the free radical pathophysiology of brain diseases.
Farooqui AA; Horrocks LA
Cell Mol Neurobiol; 1998 Dec; 18(6):599-608. PubMed ID: 9876868
[TBL] [Abstract][Full Text] [Related]
11. Deacylation and reacylation of neural membrane glycerophospholipids.
Farooqui AA; Horrocks LA; Farooqui T
J Mol Neurosci; 2000 Jun; 14(3):123-35. PubMed ID: 10984188
[TBL] [Abstract][Full Text] [Related]
12. Inhibitors of brain phospholipase A2 activity: their neuropharmacological effects and therapeutic importance for the treatment of neurologic disorders.
Farooqui AA; Ong WY; Horrocks LA
Pharmacol Rev; 2006 Sep; 58(3):591-620. PubMed ID: 16968951
[TBL] [Abstract][Full Text] [Related]
13. Polyunsaturated fatty acids and signalling via phospholipase C-beta and A2 in myocardium.
de Jonge HW; Dekkers DH; Lamers JM
Mol Cell Biochem; 1996 Apr 12-26; 157(1-2):199-210. PubMed ID: 8739247
[TBL] [Abstract][Full Text] [Related]
14. Mediators of injury in neurotrauma: intracellular signal transduction and gene expression.
Bazan NG; Rodriguez de Turco EB; Allan G
J Neurotrauma; 1995 Oct; 12(5):791-814. PubMed ID: 8594208
[TBL] [Abstract][Full Text] [Related]
15. Inhibitors of intracellular phospholipase A2 activity: their neurochemical effects and therapeutical importance for neurological disorders.
Farooqui AA; Litsky ML; Farooqui T; Horrocks LA
Brain Res Bull; 1999 Jun; 49(3):139-53. PubMed ID: 10435777
[TBL] [Abstract][Full Text] [Related]
16. Fatty acid and phospholipid selectivity of different phospholipase A2 enzymes studied by using a mammalian membrane as substrate.
Diez E; Chilton FH; Stroup G; Mayer RJ; Winkler JD; Fonteh AN
Biochem J; 1994 Aug; 301 ( Pt 3)(Pt 3):721-6. PubMed ID: 8053897
[TBL] [Abstract][Full Text] [Related]
17. Synthetic and natural inhibitors of phospholipases A2: their importance for understanding and treatment of neurological disorders.
Ong WY; Farooqui T; Kokotos G; Farooqui AA
ACS Chem Neurosci; 2015 Jun; 6(6):814-31. PubMed ID: 25891385
[TBL] [Abstract][Full Text] [Related]
18. Identification and characterization of two phospholipase A2 activities in resident mouse peritoneal macrophages.
Wightman PD; Humes JL; Davies P; Bonney RJ
Biochem J; 1981 May; 195(2):427-33. PubMed ID: 7316959
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of phospholipid hydrolysis by soluble phospholipase A2 in biological membranes of different origin after lipid peroxidation.
Balevska PS; Tjurin VA; Kassabova TA; Russanov EM; Kagan VE
Acta Physiol Pharmacol Bulg; 1986; 12(3):58-65. PubMed ID: 3811976
[TBL] [Abstract][Full Text] [Related]
20. Phospholipid-metabolizing enzymes in Alzheimer's disease: increased lysophospholipid acyltransferase activity and decreased phospholipase A2 activity.
Ross BM; Moszczynska A; Erlich J; Kish SJ
J Neurochem; 1998 Feb; 70(2):786-93. PubMed ID: 9453575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
